Moors & Cabot, Inc. Biogen Inc. Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 1,120 shares of BIIB stock, worth $176,848. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,120

Previous 1,130 0.88%

Holding current value

$176,848

Previous $261,000 16.86%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$189.07 - $236.8 $1,890 - $2,368	-10 Reduced 0.88%	1,120 $217,000
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $21,909 - $27,222	115 Added 11.33%	1,130 $261,000
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $15,477 - $19,542	73 Added 7.75%	1,015 $218,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $29,159 - $35,100	131 Added 16.15%	942 $243,000
Q3 2023 Nov 07, 2023	BUY	$253.3 - $285.89 $205,426 - $231,856	811 New	811 $208,000
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $179,698 - $234,346	-635 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $24,605 - $39,397	-95 Reduced 13.01%	635 $220,000
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $177,353 - $207,779	730 New	730 $205,000
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $209,798 - $315,799	-888 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $22,505 - $25,985	85 Added 10.59%	888 $252,000
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $207,703 - $275,067	803 New	803 $214,000
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $245,460 - $311,369	-913 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$220.06 - $304.07 $59,416 - $82,098	-270 Reduced 22.82%	913 $273,000
Q3 2019 Oct 22, 2019	BUY	$217.44 - $243.88 $22,831 - $25,607	105 Added 9.74%	1,183 $275,000
Q1 2019 May 06, 2019	SELL	$216.71 - $338.96 $233,613 - $365,398	-1,078 Reduced 50.0%	1,078 $255,000
Q1 2019 May 01, 2019	BUY	$216.71 - $338.96 $275,871 - $431,496	1,273 Added 144.17%	2,156 $510,000
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $20,887 - $26,456	75 Added 9.28%	883 $266,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $6,163 - $8,060	21 Added 2.67%	808 $286,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $9,528 - $11,355	37 Added 4.93%	787 $229,000
Q1 2018 May 18, 2018	BUY	$260.13 - $367.91 $2,601 - $3,679	10 Added 1.35%	750 $205,000
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $4,614 - $5,168	15 Added 2.07%	740 $236,000
Q3 2017 Nov 16, 2017	BUY	$281.15 - $329.69 $203,833 - $239,025	725	725 $228,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account